CD36 and obesity disorder: Similar findings were observed by several other rodent studies [22,23] and have recently been confirmed in liver biopsies of patients with NAFLD, highlighting the clinical relevance of CD36 in human liver diseases associated with obesity and type 2 diabetes [24].